David D. Chang
Executive Vice President, Chief Medical Officer
Oncology
Kite Pharma
Netherlands
Biography
Dr. Chang has an industry-leading track record of innovation in the field of oncology drug development. From 2002 to 2014, he held senior leadership roles at Amgen, including Vice President of Global Development and Head of Hematology-Oncology. During this time, Dr. Chang spearheaded personalized therapy strategies that underlied the success of Vectibix.
Research Interest
Oncology
